SSTR4 agonist 2

• Description :

  SSTR4 agonist 2 is a potent agonist of somatostatin receptor subtype 4 (SSTR4) . SSTR4 pathway inhibits nociceptive and inflammatory processes. SSTR4 agonist 2 has the potential for the research of medical disorders related to SSTR4 (extracted from patent WO2014184275A1, compound 107) [1].

• UNSPSC :

  12352005

• Target :

  Somatostatin Receptor

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/sstr4-agonist-2.html

• Purity :

  99.3900

• Solubility :

  DMSO : 100 mg/mL (ultrasonic)

• Smiles :

  CC(C)(C(C1=CC=C2)=NN(C)C1=C2C)NC([C@H]3[C@@]4([H])[C@]3([H])CNC4)=O

• Molecular Formula :

  C18H24N4O

• Molecular Weight :

  312.41

• References & Citations :

  [1]Riccardo Giovannini, et al. New somatostatin receptor subtype 4 (sstr4) agonists. Patent WO2014184275A1.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [1638589-52-2]